# Pioneer Bancorp, Inc.: financial statements, quarterly

PBFS · Nasdaq · CIK 1769663 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pbfs.md) · [Financials](/companies/pbfs/financials.md) · [Filings](/companies/pbfs/filings.md) · [Insiders](/companies/pbfs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pbfs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [3,479](/filings/0001558370-24-015316.md) | [4,178](/filings/0001558370-24-001058.md) | [3,638](/filings/0001558370-25-007177.md) | [3,659](/filings/0001558370-25-010922.md) | [3,820](/filings/0001104659-25-108497.md) | [4,577 d](/filings/0001104659-26-027092.md) | [3,651](/filings/0001104659-26-058663.md) | [3,974](/filings/0001104659-26-093436.md) | [3,630](/filings/0001104659-25-108497.md) | [4,558 d](/filings/0001104659-26-027092.md) | [3,842](/filings/0001104659-26-058663.md) | [4,263](/filings/0001104659-26-093436.md) |
| Interest expense | $k | [4,266](/filings/0001558370-24-015316.md) | [5,392](/filings/0001558370-24-001058.md) | [5,784](/filings/0001558370-24-007956.md) | [6,360 d](/filings/0001558370-24-013020.md) | [6,482](/filings/0001558370-24-015316.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [890](/filings/0001558370-24-015316.md) | [822](/filings/0001558370-24-001058.md) | [1,337](/filings/0001558370-25-007177.md) | [1,100](/filings/0001558370-25-010922.md) | [1,888](/filings/0001104659-25-108497.md) | [923 d](/filings/0001104659-26-027092.md) | [1,654](/filings/0001104659-26-058663.md) | [1,686](/filings/0001104659-26-093436.md) | [1,279](/filings/0001104659-25-108497.md) | [1,583 d](/filings/0001104659-26-027092.md) | [416](/filings/0001104659-26-058663.md) | [1,301](/filings/0001104659-26-093436.md) |
| Net income | $k | [3,419](/filings/0001558370-24-015316.md) | [3,192](/filings/0001558370-24-007956.md) | [4,719](/filings/0001104659-25-108497.md) | [3,930](/filings/0001104659-25-108497.md) | [6,308](/filings/0001104659-25-108497.md) | [3,292 d](/filings/0001104659-26-027092.md) | [5,763](/filings/0001104659-26-093436.md) | [6,451](/filings/0001104659-26-093436.md) | [4,330](/filings/0001104659-25-108497.md) | [3,743 d](/filings/0001104659-26-027092.md) | [5,290](/filings/0001104659-26-093436.md) | [3,484](/filings/0001104659-26-093436.md) |
| Diluted EPS | $ per share | [0.14](/filings/0001558370-24-015316.md) | [0.13](/filings/0001558370-24-001058.md) | [0.19](/filings/0001558370-25-007177.md) | [0.16](/filings/0001558370-25-010922.md) | [0.25](/filings/0001104659-25-108497.md) | not reported | [0.23](/filings/0001104659-26-058663.md) | [0.26](/filings/0001104659-26-093436.md) | [0.18](/filings/0001104659-25-108497.md) | not reported | [0.22](/filings/0001104659-26-058663.md) | [0.14](/filings/0001104659-26-093436.md) |
| Basic EPS | $ per share | [0.14](/filings/0001558370-24-015316.md) | [0.13](/filings/0001558370-24-001058.md) | [0.19](/filings/0001558370-25-007177.md) | [0.16](/filings/0001558370-25-010922.md) | [0.25](/filings/0001104659-25-108497.md) | not reported | [0.23](/filings/0001104659-26-058663.md) | [0.26](/filings/0001104659-26-093436.md) | [0.18](/filings/0001104659-25-108497.md) | not reported | [0.22](/filings/0001104659-26-058663.md) | [0.14](/filings/0001104659-26-093436.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,963](/filings/0001558370-23-019064.md) | [1,853](/filings/0001558370-24-001058.md) | [1,982](/filings/0001558370-24-007956.md) | [1,895](/filings/0001558370-25-002811.md) | [2,015](/filings/0001558370-24-015316.md) | [1,980](/filings/0001104659-26-027092.md) | [2,069](/filings/0001558370-25-007177.md) | [2,096](/filings/0001558370-25-010922.md) | [2,243](/filings/0001104659-25-108497.md) | [2,151](/filings/0001104659-26-093436.md) | [2,221](/filings/0001104659-26-058663.md) | [2,364](/filings/0001104659-26-093436.md) |
| Total liabilities | $m | [1,692](/filings/0001558370-23-019064.md) | [1,569](/filings/0001558370-24-001058.md) | [1,693](/filings/0001558370-24-007956.md) | [1,599](/filings/0001558370-25-002811.md) | [1,711](/filings/0001558370-24-015316.md) | [1,675](/filings/0001104659-26-027092.md) | [1,758](/filings/0001558370-25-007177.md) | [1,782](/filings/0001558370-25-010922.md) | [1,929](/filings/0001104659-25-108497.md) | [1,827](/filings/0001104659-26-093436.md) | [1,892](/filings/0001104659-26-058663.md) | [2,035](/filings/0001104659-26-093436.md) |
| Shareholders' equity | $m | [272](/filings/0001558370-24-015316.md) | [284](/filings/0001104659-25-108497.md) | [289](/filings/0001104659-25-108497.md) | [297](/filings/0001104659-26-027092.md) | [304](/filings/0001104659-25-108497.md) | [305](/filings/0001104659-26-093436.md) | [311](/filings/0001104659-26-093436.md) | [314](/filings/0001104659-26-093436.md) | [314](/filings/0001104659-25-108497.md) | [324](/filings/0001104659-26-093436.md) | [329](/filings/0001104659-26-093436.md) | [328](/filings/0001104659-26-093436.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.4](/filings/0001558370-24-015316.md) | [(0.9) d](/filings/0001104659-26-027092.md) | [3.3](/filings/0001558370-25-007177.md) | [9.0 d](/filings/0001104659-26-027092.md) | [1.9](/filings/0001558370-24-015316.md) | [14.9 d](/filings/0001104659-26-027092.md) | [(3.5)](/filings/0001104659-26-058663.md) | [5.1 d](/filings/0001104659-26-093436.md) | [3.9 d](/filings/0001104659-25-108497.md) | [5.7 d](/filings/0001104659-26-027092.md) | [(0.2)](/filings/0001104659-26-058663.md) | [14.7 d](/filings/0001104659-26-093436.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [1.2](/filings/0001558370-24-015316.md) | [1.9 d](/filings/0001104659-26-027092.md) | [1.6](/filings/0001104659-26-058663.md) | [3.3 d](/filings/0001104659-26-093436.md) | [6.0 d](/filings/0001104659-25-108497.md) | [0.4 d](/filings/0001104659-26-027092.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.2](/filings/0001558370-24-001058.md) | [25.2](/filings/0001558370-24-007956.md) | [25.2](/filings/0001558370-24-015316.md) | [25.2](/filings/0001558370-24-001058.md) | [25.2](/filings/0001558370-25-007177.md) | [25.2](/filings/0001558370-25-010922.md) | [25.2](/filings/0001104659-25-108497.md) | [24.9](/filings/0001104659-26-058663.md) | [24.6](/filings/0001104659-26-093436.md) | [24.6](/filings/0001104659-25-108497.md) | [24.3](/filings/0001104659-26-058663.md) | [24.3](/filings/0001104659-26-093436.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,841,663 at 2026-08-06, from the cover of the [10-Q filed 2026-08-10](/filings/0001104659-26-093436.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.